PCN39 Potential Time and Cost Savings with Herceptin (Trastuzumab) Subcutaneous (SC) Injection Versus Herceptin Intravenous (IV) Infusion- Results from Three Different English Patient Settings
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1232
https://www.valueinhealthjournal.com/article/S1098-3015(12)02945-2/fulltext
Title :
PCN39 Potential Time and Cost Savings with Herceptin (Trastuzumab) Subcutaneous (SC) Injection Versus Herceptin Intravenous (IV) Infusion- Results from Three Different English Patient Settings
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02945-2&doi=10.1016/j.jval.2012.08.1232
First page :
A415
Section Title :
Cancer
Open access? :
No
Section Order :
728